4
Changes in Ownership
Contineum Therapeutics, Inc. Filed Acc 0001628280-26-029435
Chief Scientific Officer sold 4,170 shares at an average $13.12 ($54,694)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lorrain Daniel S. Chief Scientific Officer | 2026-05-01 | Sale 10b5-1 | −3,870 | $13.06 | $50,542 | 143,842 | D |
| Lorrain Daniel S. Chief Scientific Officer | 2026-05-01 | Sale 10b5-1 | −300 | $13.84 | $4,152 | 143,542 | D |
| Open-market sales · 4,170 sh · avg $13.12 · $54,694 | |||||||
Loading xslF345X06/wk-form4_1777671753.xml…